Immunotherapy and chemotherapy—a practical partnership
RA Lake, BWS Robinson - Nature Reviews Cancer, 2005 - nature.com
Nature Reviews Cancer, 2005•nature.com
This article discusses how recent data have altered the way we understand how dying
tumour cells, particularly those killed by chemotherapy, engage with antitumour immune
responses. These data have significant implications for the development of new protocols
combining chemotherapy with immunotherapy, indicating an exciting potential for
therapeutic synergy with general applicability to many cancer types.
tumour cells, particularly those killed by chemotherapy, engage with antitumour immune
responses. These data have significant implications for the development of new protocols
combining chemotherapy with immunotherapy, indicating an exciting potential for
therapeutic synergy with general applicability to many cancer types.
Abstract
This article discusses how recent data have altered the way we understand how dying tumour cells, particularly those killed by chemotherapy, engage with antitumour immune responses. These data have significant implications for the development of new protocols combining chemotherapy with immunotherapy, indicating an exciting potential for therapeutic synergy with general applicability to many cancer types.
nature.com